Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated

Technology appraisal guidance
Reference number: TA387
Published: 27 April 2016
Last updated: 27 July 2016

Prostate cancer (metastatic, hormone relapsed, not treated with chemotherapy) - abiraterone acetate (with prednisolone): FAD document

Prostate cancer (metastatic, hormone relapsed, not treated with chemotherapy) - abiraterone acetate (with prednisolone): FAD document

Prostate cancer (metastatic, hormone relapsed, not treated with chemotherapy) - abiraterone acetate (with prednisolone): FAD document
14 August 2014
(218.55 Kb 3 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 14 August 2014